UPDATE: Cantor Fitzgerald Reiterates Overweight On Kadmon Holdings, Raises Target To $10 Thinks Co's KD025 Data 'is a robust data update on both efficacy and safety, supportive of US approval and a meaningful commercial opportunity'

Do you like seeing these details as to why an analyst recommended a stock? What could we do to make this product better? Let us know by emailing newsdesk@benzinga.com

Benzinga · 11/12/2019 14:20